Maestas Nicholas
SEC insider (Form 3/4/5 filer). CIK 0001871423. Chief Financial Officer at Rani Therapeutics Holdings, Inc. (RANI) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 17, 2026. Located in SAN JOSE, CA.
Companies Maestas Nicholas has filed insider reports for
- Rani Therapeutics Holdings, Inc. (RANI): Officer, Chief Financial Officer
- Tempest Therapeutics, Inc. (TPST): Officer, Chief Financial Officer
Maestas Nicholas
CIK: 0001871423
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 17, 2026RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
2M shares- - Mar 31, 2026TPST
Tempest Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
140K shares- - Jan 2, 2025TPST
Tempest Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 2,000,000 | - | - | Direct |
| Mar 31, 2026 |  TPST Tempest Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 140,000 | - | - | Direct |
| Jan 2, 2025 | TPST Tempest Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 200,000 | - | - | Direct |
1-3 of 3 transactions